Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial
Authors:
- 18 October 2023
- journal article
- review article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102144
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled HypertensionJAMA, 2023
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- 2018 ESC/ESH Guidelines for the management of arterial hypertensionEuropean Heart Journal, 2018
- Hypertension and left ventricular hypertrophyAnnals of Translational Medicine, 2017
- Global Disparities of Hypertension Prevalence and ControlCirculation, 2016
- Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendationsWiener klinische Wochenschrift, 2016